Human-centred technology. Meaningful impact.

Intelligence built to make a difference.

JazyNova Technologies develops AI-powered software and intelligent systems for healthcare, security, commerce and business operations — with cancer-related innovation as our leading priority.

Founder-led technology project · Estonia / European development ambition
Healthcare firstPatient-centred innovation
AI + VisionSoftware and devices
ModularUse-case driven systems
Technology foundationsArtificial IntelligenceComputer VisionData & AnalyticsConnected DevicesWorkflow Automation
Who we are

One technology vision. Multiple real-world applications.

JazyNova Technologies is a founder-led technology project bringing together artificial intelligence, computer vision, data analysis, digital workflows and connected hardware.

Our ambition is to transform practical ideas into clearly scoped, testable products that respond to real needs. We develop across several sectors, while placing healthcare innovation and cancer-related applications at the centre of our impact agenda.

  • Build useful, human-centred AI tools.
  • Connect software, data and intelligent devices.
  • Develop responsibly through testing and expert collaboration.
  • Prepare solutions for institutional and international markets.
AI-enabled medical research environment in a modern Estonian-inspired laboratoryAI, medical imaging and human expertise
Our leading priority

Advancing cancer care through responsible AI.

We are exploring digital tools that can support screening pathways, image review and continuity of care. The goal is to assist healthcare professionals and patient-centred services — not replace clinical judgement.

Medical imaging workflow and AI-assisted visual analysis
Flagship healthcare initiative

Cervical AI

AI-assisted cervical screening support, image-quality assessment and patient navigation concepts, with a focus on settings where access to screening and specialist resources may be constrained.

Explore the healthcare portfolio ↗
✚

MAD Breast AI

A breast-health AI initiative exploring image-based analysis support and clinical decision-support workflows.

◎

Lymphoma AI

A patient-centred concept for early-detection support, decision support and continuity across the lymphoma care pathway.

♡

Patient-centred by design

Technology should strengthen access, understanding and care coordination while keeping people and qualified professionals at the centre.

Solutions portfolio

Technology designed around practical needs.

Healthcare is our priority. Beyond cancer-related innovation, our portfolio explores visual intelligence, connected retail, digital services and operational automation.

Medical image analysis workflow
Healthcare AI

Cervical AI

AI-assisted cervical screening support and patient navigation.

Prototype / technical refinement
Medical AI laboratory and imaging research
Healthcare AI

MAD Breast AI

Breast-health image analysis support concept and clinical workflow exploration.

Concept / development initiative
Digital patient care and imaging support
Healthcare AI

Lymphoma AI

Patient-centred early-detection support and care-pathway continuity concept.

Development initiative
AI-assisted video monitoring and visual security analysis
Computer vision

Intelligent Security

Camera-based monitoring concepts, event analysis and visual validation for defined operational environments.

Architecture / prototype concepts
Connected smart shopping cart in a modern store
Smart commerce

Smart Cart & Intelligent Kiosks

Connected retail-cart and guided digital-service concepts to support product identification and service access.

Concept / prototype exploration
Business team using an analytics dashboard
Enterprise intelligence

Business AI & Digital Audit

Digital process review, operational insights, workflow automation and performance-support tools.

Tools / concepts in development
Product maturity matters. The portfolio contains initiatives at different stages, from architecture and concepts to prototypes and technical refinement. No clinical approval, regulatory certification, completed clinical validation or full commercial deployment is claimed on this website.
Beyond healthcare

Useful intelligence across connected environments.

Our wider technology work applies AI, data and automation to improve how organisations monitor, serve customers and manage operations.

Security monitoring workspace

Visual analysis & monitoring

Video review, visual validation and event-flagging concepts. Human review, privacy safeguards and lawful use remain essential.

Smart cart and digital retail service

Smart commerce & service access

Connected carts, touchscreens, kiosks and guided workflows for retail and service environments.

Business analytics and collaboration

Digital operations & AI marketing

Enterprise dashboards, process automation, customer operations and prospect-management support.

Research recognition & international scientific selection

Research contributions selected across major international cancer meetings.

JazyNova’s health-technology research pathway spans cervical, breast, paediatric blood and pancreatic cancers, as well as multimodal oncology research. The records below identify the scientific events and the exact acceptance status documented for each contribution.

ESMO Asia Congress 2026

MAD Breast AI

Singapore · 4–6 December 2026

Poster presentation accepted · display
“MAD Breast AI: An Artificial Intelligence System for Early Breast Cancer Detection.”
Scientific committee: ESMO Asia 2026 Scientific Committee
Abstract number: #926
Format: Poster presentation (display)
Event: ESMO Asia Congress 2026, Singapore
Poster requirement: Paper poster and ePoster; ePoster upload deadline stated in acceptance email: 26 November 2026
AACR · Pediatric Cancer Research 2026

MAD Leukemia AI

Philadelphia, United States · 22–25 September 2026

Poster accepted
“MAD Leukemia AI: A Deep Learning-Based Artificial Intelligence System for Early Risk Stratification in Pediatric Acute Lymphoblastic Leukemia.”
Organisation: American Association for Cancer Research (AACR)
Event: AACR Special Conference on Pediatric Cancer Research
Presentation: 24 September 2026, 5:30–7:30 PM (as recorded in scientific profile)
Focus: Deep learning and early risk stratification in paediatric acute lymphoblastic leukemia
UICC · World Cancer Congress 2026

Cervical cancer screening support

Hong Kong · September 2026

Abstract accepted · ePoster
“Leveraging Artificial Intelligence for Cervical Cancer Screening Support in Low-Resource Settings: A Visual Deep Learning Approach.”
Organisation: Union for International Cancer Control (UICC)
Event: World Cancer Congress 2026
Reference: Abstract #000399
Format: ePoster in the abstract eLibrary
IGCS · IGCAN 2026

Patient-centred cervical AI

Montreal, Canada · 3 October 2026

Poster accepted
“Patient-Centered Artificial Intelligence for Cervical Cancer Screening and Navigation in Low-Resource Settings.”
Organisations: International Gynecologic Cancer Society (IGCS) and International Gynecologic Cancer Advocacy Network (IGCAN)
Event: IGCS–IGCAN Gynecologic Cancer Advocacy Summit 2026
Poster ID: 2026--2154482690
Format: Scientific/advocacy poster
AACR · Pancreatic Cancer 2026

IFOCOM Pancreas AI

San Diego, United States · 25–28 September 2026

Poster accepted · as listed in scientific profile
“IFOCOM Pancreas AI: A Deep Learning-Based Artificial Intelligence System for Early Detection and Clinical Decision Support in Pancreatic Cancer.”
Organisation: American Association for Cancer Research (AACR)
Event: AACR Conference on Pancreatic Cancer
Location: San Diego, United States
Session details: Not specified in the supplied scientific profile
Cell Press Symposia · 2026

IFOCOM Precision AI

Hallmarks of Cancer · Sitges, Spain · 1–3 November 2026

Poster accepted · as listed in scientific profile
“IFOCOM Precision AI: Decoding Systemic Determinants of Cancer through Multimodal Artificial Intelligence.”
Scientific organiser: Cell Press Symposia
Event: Hallmarks of Cancer
Location: Sitges, Spain
Focus: Multimodal AI and systemic determinants of cancer
How to read these selections: Acceptance refers to abstracts or posters selected for scientific presentation.
Technology approach

A modular foundation. Built for responsible development.

Individual products can share reusable technical components while keeping separate workflows, permissions and deployment requirements.

01 / INTELLIGENCE

AI & Machine Learning

Model development and inference for clearly defined use cases.

02 / VISUAL DATA

Computer Vision

Image and video analysis, including object and event recognition.

03 / DATA LAYER

Data & Integration

Databases, analytics and API-based system connections.

04 / USER EXPERIENCE

Applications

Web and mobile interfaces, dashboards and operational workflows.

05 / CONNECTIVITY

Connected Devices

Cameras, kiosks, smart carts and edge devices where applicable.

06 / TRUST

Responsible systems

Privacy, cybersecurity, interoperability and human oversight as design priorities.

From concept to deployment

How we intend to build.

A disciplined development path: focus, test, learn and scale only when the evidence supports it.

Define the use case

Prioritise the product, users, requirements and ownership of intellectual property.

Validate the technology

Document functionality, run technical tests and improve reliability.

Engage users & experts

Conduct user discovery and seek appropriate research, clinical and industry collaboration.

Pilot and refine

Run limited pilots with safeguards, measure outcomes and refine the model before expansion.

Founders & leadership

Two complementary perspectives. One technology ambition.

JazyNova Technologies is led by two co-founders bringing together technology entrepreneurship, healthcare experience and a commitment to practical innovation.

Ibrahima Madougou Moubarak, Co-Founder and CEO of JazyNova Technologies
Co-Founder & CEO

Ibrahima Madougou Moubarak

Strategy · Product vision · Partnerships

Ibrahima Madougou Moubarak is an entrepreneur and public-interest leader working at the intersection of technology, AI innovation and healthcare advocacy. He leads JazyNova’s strategic direction, product vision, organisational development and partnership engagement.

He is the founder and President of the Ligue Nigérienne de Lutte contre le Cancer (LNLC-Niger), with experience in cancer prevention, awareness, advocacy and patient support. His international engagement includes work with cancer-control and patient-advocacy networks.

His academic background includes a Master 2 Research in Public Law. His work at JazyNova connects technology development with institutional strategy and real-world needs.

AI & technology innovationHealthcare advocacyStrategic leadership
Illa Godi Bitrus, Co-Founder and Healthcare Innovation Coordinator of JazyNova Technologies
Co-Founder · Healthcare Innovation

Illa Godi Bitrus

Medical expertise · Digital health · Healthcare innovation

Illa Godi Bitrus is a medical doctor and healthcare innovation professional whose work combines clinical medicine, public health programmes, epidemiological monitoring and digital health initiatives.

His professional experience includes medical work with MSF Switzerland on a malaria programme in Gouré, Niger, where he contributed to clinical care, epidemiological monitoring and medical data reporting. His background also includes community health activities, medical coordination and data operations.

At JazyNova, his profile supports the healthcare innovation perspective, helping connect product development with clinical workflows, public-health needs and responsible digital-health use cases.

Doctor of Medicine (MD)Digital healthPublic health & epidemiology
Our European ambition

Exploring Estonia as a base for the next chapter.

JazyNova is exploring Estonia as a potential base for company establishment, technology development, partnerships and access to the wider European market.

We see this next phase as an opportunity to structure the venture, strengthen technical validation, engage with specialist talent and develop products in a responsible, internationally connected environment.

PHASE 01Establishment, product prioritisation and intellectual-property review.
PHASE 02Technical validation and product refinement.
PHASE 03User discovery and appropriate partner engagement.
PHASE 04Controlled pilots, outcome measurement and iteration.
PHASE 05Repeatable delivery and expansion into European markets.
Modern innovation and medical AI workspace inspired by Estonia
People & expertise

A founder-led project built to grow with the right expertise.

JazyNova is currently founder-led. As products progress, the project intends to engage specialist contributors and build the capabilities needed for responsible delivery.

Current leadership

Ibrahima Madougou Moubarak
Founder & CEO — strategic direction, product vision, organisational development and partnership engagement.

Capabilities to build

AI engineering · Computer vision · Healthcare technology · Clinical and regulatory expertise · Data science · Enterprise intelligence · Hardware and IoT integration.

These are capability areas and future collaboration priorities, not a claim that all roles are currently filled by employees.
Clarity & transparency

Questions about JazyNova.

We believe a strong technology venture should communicate clearly about what exists today and what still needs to be built.

Is JazyNova Technologies already incorporated in Estonia?

JazyNova is presented here as a technology project under development and is exploring Estonia as a potential base. This website does not claim that an Estonian company has already been incorporated.

Are the healthcare AI products clinically approved?

No clinical approval or regulatory certification is claimed. Clinical evaluation, regulatory assessment, data protection and qualified healthcare-professional oversight are necessary before clinical deployment.

Does JazyNova work only in healthcare?

No. Cancer-related healthcare innovation is our leading priority, alongside intelligent security, smart commerce, business intelligence, AI marketing and smart mobility concepts.

Does the project have a full employee team today?

The project is currently founder-led. Specialist capabilities are identified as future recruitment and collaboration priorities as the venture develops.

How can an organisation explore collaboration?

Institutions, research groups, technology specialists and potential pilot users can contact the founder to discuss relevant opportunities.

Let’s build what matters

Interested in a conversation?

We welcome discussions with research, healthcare, technology and industry stakeholders.

✉ jazyholdingroup@gmail.com

☎ +221 76 173 71 87

⌖ Mermoz Station Elton, Dakar, Senegal

Contact JazyNova ↗